302 related articles for article (PubMed ID: 34763896)
21. Utility of Serum Biomarkers in the Diagnosis and Stratification of Mild Traumatic Brain Injury.
Lewis LM; Schloemann DT; Papa L; Fucetola RP; Bazarian J; Lindburg M; Welch RD
Acad Emerg Med; 2017 Jun; 24(6):710-720. PubMed ID: 28170122
[TBL] [Abstract][Full Text] [Related]
22. Sex differences in time course and diagnostic accuracy of GFAP and UCH-L1 in trauma patients with mild traumatic brain injury.
Papa L; Brophy GM; Alvarez W; Hirschl R; Cress M; Weber K; Giordano P
Sci Rep; 2023 Jul; 13(1):11833. PubMed ID: 37481589
[TBL] [Abstract][Full Text] [Related]
23. Ability of Serum Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and S100B To Differentiate Normal and Abnormal Head Computed Tomography Findings in Patients with Suspected Mild or Moderate Traumatic Brain Injury.
Welch RD; Ayaz SI; Lewis LM; Unden J; Chen JY; Mika VH; Saville B; Tyndall JA; Nash M; Buki A; Barzo P; Hack D; Tortella FC; Schmid K; Hayes RL; Vossough A; Sweriduk ST; Bazarian JJ
J Neurotrauma; 2016 Jan; 33(2):203-14. PubMed ID: 26467555
[TBL] [Abstract][Full Text] [Related]
24. NRGN, S100B and GFAP levels are significantly increased in patients with structural lesions resulting from mild traumatic brain injuries.
Çevik S; Özgenç MM; Güneyk A; Evran Ş; Akkaya E; Çalış F; Katar S; Soyalp C; Hanımoğlu H; Kaynar MY
Clin Neurol Neurosurg; 2019 Aug; 183():105380. PubMed ID: 31234132
[TBL] [Abstract][Full Text] [Related]
25. Clinical value of S100B in detecting intracranial injury in elderly patients with mild traumatic brain injury.
Santing JAL; Hopman JH; Verheul RJ; van der Naalt J; van den Brand CL; Jellema K
Injury; 2024 Mar; 55(3):111313. PubMed ID: 38219558
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic performance of biomarker S100B and guideline adherence in routine care of mild head trauma.
Faisal M; Vedin T; Edelhamre M; Forberg JL
Scand J Trauma Resusc Emerg Med; 2023 Jan; 31(1):3. PubMed ID: 36624501
[TBL] [Abstract][Full Text] [Related]
27. Microwave scan and brain biomarkers to rule out intracranial hemorrhage: study protocol of a planned prospective study (MBI01).
Vedin T; Bergenfeldt H; Holmström E; Lundager-Forberg J; Edelhamre M
Eur J Trauma Emerg Surg; 2022 Apr; 48(2):1335-1342. PubMed ID: 33944977
[TBL] [Abstract][Full Text] [Related]
28. S100B vs. "GFAP and UCH-L1" assays in the management of mTBI patients.
Oris C; Bouillon-Minois JB; Kahouadji S; Pereira B; Dhaiby G; Defrance VB; Durif J; Schmidt J; Moustafa F; Bouvier D; Sapin V
Clin Chem Lab Med; 2024 Apr; 62(5):891-899. PubMed ID: 38033294
[TBL] [Abstract][Full Text] [Related]
29. The diagnostic values of UCH-L1 in traumatic brain injury: A meta-analysis.
Shahjouei S; Sadeghi-Naini M; Yang Z; Kobeissy F; Rathore D; Shokraneh F; Blackburn S; Manley GT; Wang KKW
Brain Inj; 2018; 32(1):1-17. PubMed ID: 29087740
[TBL] [Abstract][Full Text] [Related]
30. Modeling the Kinetics of Serum Glial Fibrillary Acidic Protein, Ubiquitin Carboxyl-Terminal Hydrolase-L1, and S100B Concentrations in Patients with Traumatic Brain Injury.
Welch RD; Ellis M; Lewis LM; Ayaz SI; Mika VH; Millis S; Papa L
J Neurotrauma; 2017 Jun; 34(11):1957-1971. PubMed ID: 28031000
[TBL] [Abstract][Full Text] [Related]
31. S100B outperforms clinical decision rules for the identification of intracranial injury on head CT scan after mild traumatic brain injury.
Jones CMC; Harmon C; McCann M; Gunyan H; Bazarian JJ
Brain Inj; 2020 Feb; 34(3):407-414. PubMed ID: 32064945
[No Abstract] [Full Text] [Related]
32. Temporal response profiles of serum ubiquitin C-terminal hydrolase-L1 and the 145-kDa alpha II-spectrin breakdown product after severe traumatic brain injury in children.
Metzger RR; Sheng X; Niedzwecki CM; Bennett KS; Morita DC; Zielinski B; Schober ME
J Neurosurg Pediatr; 2018 Oct; 22(4):369-374. PubMed ID: 29957142
[TBL] [Abstract][Full Text] [Related]
33. Blood biomarkers on admission in acute traumatic brain injury: Relations to severity, CT findings and care path in the CENTER-TBI study.
Czeiter E; Amrein K; Gravesteijn BY; Lecky F; Menon DK; Mondello S; Newcombe VFJ; Richter S; Steyerberg EW; Vyvere TV; Verheyden J; Xu H; Yang Z; Maas AIR; Wang KKW; Büki A;
EBioMedicine; 2020 Jun; 56():102785. PubMed ID: 32464528
[TBL] [Abstract][Full Text] [Related]
34. Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein.
Diaz-Arrastia R; Wang KK; Papa L; Sorani MD; Yue JK; Puccio AM; McMahon PJ; Inoue T; Yuh EL; Lingsma HF; Maas AI; Valadka AB; Okonkwo DO; Manley GT;
J Neurotrauma; 2014 Jan; 31(1):19-25. PubMed ID: 23865516
[TBL] [Abstract][Full Text] [Related]
35. Comparing blood biomarkers to clinical decision rules to select patients suspected of traumatic brain injury for head computed tomography.
Li Y; Ding VY; Chen H; Zhu G; Jiang B; Boothroyd D; Rezaii PG; Bet AM; Paulino AD; Weber A; Glushakova OY; Hayes RL; Wintermark M
Neuroradiol J; 2023 Feb; 36(1):68-75. PubMed ID: 35588232
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic performance of S100B protein serum measurement in detecting intracranial injury in children with mild head trauma.
Manzano S; Holzinger IB; Kellenberger CJ; Lacroix L; Klima-Lange D; Hersberger M; La Scala G; Altermatt S; Staubli G
Emerg Med J; 2016 Jan; 33(1):42-6. PubMed ID: 26283067
[TBL] [Abstract][Full Text] [Related]
37. Serum biomarkers identify critically ill traumatic brain injury patients for MRI.
Richter S; Winzeck S; Czeiter E; Amrein K; Kornaropoulos EN; Verheyden J; Sugar G; Yang Z; Wang K; Maas AIR; Steyerberg E; Büki A; Newcombe VFJ; Menon DK;
Crit Care; 2022 Nov; 26(1):369. PubMed ID: 36447266
[TBL] [Abstract][Full Text] [Related]
38. Blood biomarkers of mild traumatic brain injury: State of art.
Sapin V; Gaulmin R; Aubin R; Walrand S; Coste A; Abbot M
Neurochirurgie; 2021 May; 67(3):249-254. PubMed ID: 33482234
[TBL] [Abstract][Full Text] [Related]
39. The Levels of Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 During the First Week After a Traumatic Brain Injury: Correlations With Clinical and Imaging Findings.
Posti JP; Takala RS; Runtti H; Newcombe VF; Outtrim J; Katila AJ; Frantzén J; Ala-Seppälä H; Coles JP; Hossain MI; Kyllönen A; Maanpää HR; Tallus J; Hutchinson PJ; van Gils M; Menon DK; Tenovuo O
Neurosurgery; 2016 Sep; 79(3):456-64. PubMed ID: 26963330
[TBL] [Abstract][Full Text] [Related]
40. A systematic review and meta-analysis of major blood protein biomarkers that predict unfavorable outcomes in severe traumatic brain injury.
Behzadi F; Luy DD; Schaible PA; Zywiciel JF; Puccio AM; Germanwala AV
Clin Neurol Neurosurg; 2024 Jul; 242():108312. PubMed ID: 38733758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
